⌘K

Login Start Free

Home/Filings/4/0000950170-25-043880

4//SEC Filing

Kowieski Mark 4

Accession 0000950170-25-043880

CIK 0001403708other

View on SEC.gov Company Profile

Filed

Mar 23, 8:00 PM ET

Accepted

Mar 24, 4:30 PM ET

Size

4.5 KB

Accession

0000950170-25-043880

Insider Transaction Report

Form 4

Period: 2025-03-20

Evoke Pharma IncEVOK

Chief Financial Officer

Transactions

Award
Common Stock
2025-03-20$3.21/sh+4,500$14,463→ 4,916 total

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

Evoke Pharma Inc

CIK 0001403708

Entity typeother

Related Parties

1

filerCIK 0002024869

Filing Metadata

Form type: 4
Filed: Mar 23, 8:00 PM ET
Accepted: Mar 24, 4:30 PM ET
Size: 4.5 KB

View on SEC.gov